BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling

M Sung1, P Giannakakou1

  • 1Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA.

Oncogene
|March 26, 2013
PubMed

Insights

Breast cancer gene 1 (BRCA1) loss increases microtubule dynamics, reducing paclitaxel (PTX) efficacy in cancer cells. This BRCA1 knockdown confers taxane resistance by impairing PTX-induced microtubule stabilization and apoptosis.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Taxanes are crucial chemotherapy drugs, but drug resistance limits their effectiveness.
  • The molecular mechanisms of taxane resistance are not fully understood.
  • BRCA1 expression correlates with taxane sensitivity, but its role is unclear.

Purpose of the Study:

  • To investigate the role of BRCA1 in microtubule dynamics and response to taxane treatment.
  • To elucidate the molecular mechanisms linking BRCA1 expression to taxane resistance.

Main Methods:

  • Created a stable BRCA1 knockdown A549 cell line (B1-KD).
  • Assessed microtubule dynamics using live-cell confocal microscopy with fluorescently tagged tubulin and EB1.
  • Evaluated paclitaxel (PTX) efficacy using immunofluorescence microscopy and tubulin polymerization assays.
  • Measured PTX binding to microtubules and pro-caspase-8 association.

Main Results:

  • BRCA1 knockdown (B1-KD) conferred resistance to paclitaxel (PTX).
  • B1-KD cells showed increased microtubule dynamics and impaired PTX-induced microtubule polymerization.
  • Loss of BRCA1 reduced PTX binding to microtubules and pro-caspase-8 association with microtubules.
  • BRCA1 loss led to impaired PTX-induced apoptosis.

Conclusions:

  • BRCA1 indirectly regulates microtubule dynamics and stability.
  • Loss of BRCA1 results in more dynamic microtubules, less susceptible to PTX stabilization.
  • BRCA1 deficiency contributes to taxane resistance by altering microtubule properties and apoptotic signaling.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...